BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28860779)

  • 1. Erratum: Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum].
    Neuropsychiatr Dis Treat; 2017; 13():2219. PubMed ID: 28860779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report.
    Terao T; Ishida A; Kimura T; Yoshida M; Hara T
    Neuropsychiatr Dis Treat; 2017; 13():1441-1448. PubMed ID: 28652744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum.
    Paediatr Child Health; 2015; 20(8):466-7. PubMed ID: 26744561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2017; 12():231. PubMed ID: 28138232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].
    Clin Ophthalmol; 2015; 9():1365. PubMed ID: 26229429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].
    Clin Ophthalmol; 2015; 9():453. PubMed ID: 25834381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Burden of comorbidities among Japanese patients with atrial fibrillation: a case study of dyspepsia [Corrigendum].
    Clin Exp Gastroenterol; 2013; 6():193. PubMed ID: 24098088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum].
    Onco Targets Ther; 2017; 10():1709. PubMed ID: 28356758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum].
    Int J Womens Health; 2015; 7():403. PubMed ID: 25960676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3587. PubMed ID: 30464440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Confirmation of the factorial structure of the Japanese short version of the TEMPS-A in psychiatric patients and general adults [Corrigendum].
    Neuropsychiatr Dis Treat; 2017; 13():767-768. PubMed ID: 28331327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum].
    Clin Ophthalmol; 2017; 11():619. PubMed ID: 28435211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate-severe Gram-positive infections [Corrigendum].
    Infect Drug Resist; 2019; 12():431. PubMed ID: 30863125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum].
    Clin Ophthalmol; 2019; 13():215. PubMed ID: 30774301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum].
    Clin Ophthalmol; 2018; 12():2637. PubMed ID: 30587910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Uncovering the etiology of conversion disorder: insights from functional neuroimaging [Corrigendum].
    Neuropsychiatr Dis Treat; 2016; 12():779. PubMed ID: 27103807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum].
    Clin Ophthalmol; 2017; 11():303. PubMed ID: 28223773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum.
    Sun XH; Yu HZ; Yang MM; Yang YM; Dang ZM
    J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):192. PubMed ID: 26140254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Efficacy and effectiveness trials have different goals, use different tools, and generate different messages [Corrigendum].
    Pragmat Obs Res; 2016; 7():1. PubMed ID: 27801423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1031-1033. PubMed ID: 27274224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.